Newbridge Financial Services Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660 | Hold |
300
| – | – | ﹤0.01% | 1229 |
|
|
2025
Q1 | $348 | Hold |
300
| – | – | ﹤0.01% | 983 |
|
|
2024
Q4 | $381 | Hold |
300
| – | – | ﹤0.01% | 1066 |
|
|
2024
Q3 | $1.02K | Hold |
300
| – | – | ﹤0.01% | 595 |
|
|
2024
Q2 | $1.4K | Sell |
300
-200
| -40% | -$934 | ﹤0.01% | 978 |
|
|
2024
Q1 | $3.71K | Buy |
500
+200
| +67% | +$1.48K | ﹤0.01% | 925 |
|
|
2023
Q4 | $3.04K | Sell |
300
-3,000
| -91% | -$30.4K | ﹤0.01% | 925 |
|
|
2023
Q3 | $25.7K | Sell |
3,300
-821
| -20% | -$6.4K | 0.01% | 586 |
|
|
2023
Q2 | $33.9K | Hold |
4,121
| – | – | 0.02% | 553 |
|
|
2023
Q1 | $29.9K | Sell |
4,121
-1,491
| -27% | -$10.8K | 0.02% | 593 |
|
|
2022
Q4 | $49.8K | Sell |
5,612
-170
| -3% | -$1.51K | 0.03% | 464 |
|
|
2022
Q3 | $71K | Buy |
5,782
+5,470
| +1,753% | +$67.2K | 0.04% | 365 |
|
|
2022
Q2 | $4K | Sell |
312
-23
| -7% | -$295 | ﹤0.01% | 1047 |
|
|
2022
Q1 | $6K | Sell |
335
-185
| -36% | -$3.31K | ﹤0.01% | 1054 |
|
|
2021
Q4 | $14K | Buy |
520
+160
| +44% | +$4.31K | 0.01% | 832 |
|
|
2021
Q3 | $15K | Sell |
360
-2,425
| -87% | -$101K | 0.01% | 745 |
|
|
2021
Q2 | $158K | Buy |
2,785
+2,007
| +258% | +$114K | 0.1% | 210 |
|
|
2021
Q1 | $33K | Sell |
778
-185
| -19% | -$7.85K | 0.02% | 526 |
|
|
2020
Q4 | $68K | Buy |
963
+327
| +51% | +$23.1K | 0.06% | 268 |
|
|
2020
Q3 | $18K | Buy |
+636
| New | +$18K | 0.02% | 527 |
|